P21(waf1/cip1) protein expression in normal, hyperplastic and malignant endometrium. Correlation with hormone receptor status, c-erbB-2 oncoprotein, bcl-2 and other cell cycle related proteins (Rb, p53, Ki-67, PCNA)
dc.contributor.author | Ioachim, E. | en |
dc.contributor.author | Kitsiou, E. | en |
dc.contributor.author | Mitselou, A. | en |
dc.contributor.author | Zagorianakou, N. | en |
dc.contributor.author | Charalabopoulos, K. | en |
dc.contributor.author | Salmas, M. | en |
dc.contributor.author | Makrydimas, G. | en |
dc.contributor.author | Vougiouklakis, T. | en |
dc.contributor.author | Agnantis, N. J. | en |
dc.date.accessioned | 2015-11-24T19:00:20Z | |
dc.date.available | 2015-11-24T19:00:20Z | |
dc.identifier.issn | 0204-3564 | - |
dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/19512 | |
dc.rights | Default Licence | - |
dc.subject | p21 (waf1/cip1) | en |
dc.subject | er | en |
dc.subject | pr | en |
dc.subject | p53 | en |
dc.subject | rb | en |
dc.subject | pcna | en |
dc.subject | ki-67 | en |
dc.subject | endometrial lesions | en |
dc.subject | kinase inhibitor p21 | en |
dc.subject | prognostic-significance | en |
dc.subject | p53-independent expression | en |
dc.subject | proliferative activity | en |
dc.subject | estrogen-receptor | en |
dc.subject | carcinoma | en |
dc.subject | cancer | en |
dc.subject | adenocarcinoma | en |
dc.subject | survival | en |
dc.subject | apoptosis | en |
dc.title | P21(waf1/cip1) protein expression in normal, hyperplastic and malignant endometrium. Correlation with hormone receptor status, c-erbB-2 oncoprotein, bcl-2 and other cell cycle related proteins (Rb, p53, Ki-67, PCNA) | en |
heal.abstract | Defects in the mechanisms controlling the cell cycle are crucial in cell transformation and/or tumor progression. p21(waf1/cip1) is an inhibitor of cyclin-dependent kinases, induced by p53-dependent and p53-independent pathways, which can block progression through the cell cycle. p21 (waf1/cip1) expression has been investigated, immunohistochemically in a series of 115 endometrial carcinomas, 62 cases of endometrial hyperplasias, and 62 cases of normal endometium. (33 in proliferative phase and 29 in secretoty). The association between p21(waf1/cip1) expression with hormone receptor status, c-erbB-2 and other cell cycle, related proteins p53, Rb, Ki-67, PCNA) was assessed by univariate analysis. Nuclear p21 (waf1/cip1) expression was statistically higher in the group of carcinomas compared with normal proliferative (p=0.005) and secretory (p=0.0012) endometrium. In addition, this expression was higher in hyperplastic lesions compared with normal proliferative (p=0.02) and secretory (p=0.04) endometrium. A statistically significant positive relationship of p21(waf1/cip1) expression with progesterone receptor status (p=0.007), p53 protein (p=0.001), pRb (p<0.0001) and the two proliferative associated indices Ki-67 and PCNA (p<0.0001) was observed. These data indicate that the expression of p21 (waf1/cip1) protein seems to be an early event in endometrial carcinogenesis and is strongly associated with other cell cycle related proteins. | en |
heal.access | campus | - |
heal.fullTextAvailability | TRUE | - |
heal.identifier.secondary | <Go to ISI>://000186162400008 | - |
heal.journalName | Exp Oncol | en |
heal.journalType | peer-reviewed | - |
heal.language | en | - |
heal.publicationDate | 2003 | - |
heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
heal.type | journalArticle | - |
heal.type.el | Άρθρο Περιοδικού | el |
heal.type.en | Journal article | en |
Αρχεία
Φάκελος/Πακέτο αδειών
1 - 1 of 1
Φόρτωση...
- Ονομα:
- license.txt
- Μέγεθος:
- 1.74 KB
- Μορφότυπο:
- Item-specific license agreed upon to submission
- Περιγραφή: